CG
GSK icon

Caprock Group’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$772K Sell
19,752
-190
-1% -$7.43K 0.02% 553
2024
Q4
$684K Buy
19,942
+1,424
+8% +$48.8K 0.02% 521
2024
Q3
$764K Sell
18,518
-7,482
-29% -$309K 0.03% 461
2024
Q2
$1.01M Buy
26,000
+13,943
+116% +$542K 0.04% 366
2024
Q1
$522K Buy
12,057
+544
+5% +$23.5K 0.03% 398
2023
Q4
$430K Buy
11,513
+317
+3% +$11.8K 0.03% 430
2023
Q3
$409K Sell
11,196
-4,183
-27% -$153K 0.03% 411
2023
Q2
$553K Buy
15,379
+1,259
+9% +$45.3K 0.04% 355
2023
Q1
$507K Buy
14,120
+2,338
+20% +$83.9K 0.04% 358
2022
Q4
$419K Sell
11,782
-2,013
-15% -$71.5K 0.04% 328
2022
Q3
$410K Sell
13,795
-2,243
-14% -$66.7K 0.04% 324
2022
Q2
$703K Buy
16,038
+1,050
+7% +$46K 0.07% 212
2022
Q1
$662K Buy
14,988
+6,617
+79% +$292K 0.06% 235
2021
Q4
$374K Buy
+8,371
New +$374K 0.03% 355
2021
Q3
Sell
-5,686
Closed -$229K 559
2021
Q2
$229K Buy
+5,686
New +$229K 0.02% 459
2020
Q4
Sell
-8,666
Closed -$339K 483
2020
Q3
$339K Sell
8,666
-18,290
-68% -$715K 0.05% 267
2020
Q2
$1.11M Buy
26,956
+7,674
+40% +$317K 0.17% 108
2020
Q1
$735K Buy
19,282
+12,052
+167% +$459K 0.14% 116
2019
Q4
$343K Buy
7,230
+1,375
+23% +$65.2K 0.06% 223
2019
Q3
$253K Buy
5,855
+216
+4% +$9.33K 0.05% 269
2019
Q2
$229K Sell
5,639
-873
-13% -$35.5K 0.04% 279
2019
Q1
$280K Sell
6,512
-1,268
-16% -$54.5K 0.05% 276
2018
Q4
$301K Buy
7,780
+982
+14% +$38K 0.07% 239
2018
Q3
$276K Buy
6,798
+534
+9% +$21.7K 0.06% 290
2018
Q2
$256K Buy
6,264
+838
+15% +$34.2K 0.05% 334
2018
Q1
$216K Buy
+5,426
New +$216K 0.05% 374
2017
Q4
Sell
-21,191
Closed -$871K 476
2017
Q3
$871K Sell
21,191
-88
-0.4% -$3.62K 0.18% 116
2017
Q2
$929K Sell
21,279
-1,261
-6% -$55.1K 0.21% 103
2017
Q1
$950K Buy
22,540
+1,191
+6% +$50.2K 0.22% 84
2016
Q4
$822K Sell
21,349
-22,881
-52% -$881K 0.21% 103
2016
Q3
$1.91M Sell
44,230
-160
-0.4% -$6.9K 0.43% 50
2016
Q2
$1.92M Sell
44,390
-643
-1% -$27.9K 0.47% 51
2016
Q1
$1.83M Buy
+45,033
New +$1.83M 0.43% 45